Mass General Brigham’s location in the Massachusetts biotech and academic medical communities creates enhanced collaborations with partners from academia, industry, and venture capital to help stimulate the development of our discoveries into lifesaving therapies for our patients.
The greatest minds at our hospitals have a history of pushing the boundaries of medicine and leading innovative science for over 200 years. We have a legacy of medical achievement, with numerous medical firsts and 13 Nobel Laureates.
Researchers at Mass Eye and Ear and Northeastern University have uncovered a previously unidentified immune response to viruses inside the nose.
In the first procedure, a team from Brigham and Women’s Hospital and Boston Children’s Hospital successfully performed an in utero cerebrovascular surgery to treat a vascular malformation in an infant’s brain before birth.
Anahita Dua, MD, MBA, MSc, and colleagues found that transcatheter arterialization of the deep veins was safe and could be performed with a high degree of procedural success in patients with chronic limb-threatening ischemia who had no conventional revascularization options and would likely be amputated.
Ongoing collaboration between physicians from Massachusetts General Hospital and Brigham and Women’s Hospital has established the Brachial Plexus & Nerve Disorders Program at Mass General Brigham, serving patients with rare and complex upper body nerve injuries and neuromuscular conditions.
Liron Bar-Peled, PhD, and his team have developed a new technology that quickly maps cancer specimens and their proteins to generate lists of druggable targets within two or three days.
Osteoporosis can be treated with parathyroid hormone-based medications that stimulate bone formation. Massachusetts General Hospital researchers identified a new compound that influences components of the parathyroid hormone signaling pathway.